Abivax SA’s chief executive said major pharmaceutical companies can’t ignore the potential of his firm’s experimental inflammatory bowel disease drug, as the industry looks to replace hundreds of billions of dollars in sales set to evaporate due to patent losses.
www.bloomberg.com
#Abivax #CEO #Big #Pharma #Ignore #Experimental #Drug
Abivax CEO Says Big Pharma Can’t Ignore Its Experimental Drug
